OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.27
Delayed Data
As of Apr 17
 -0.03 / -1.30%
Today’s Change
1.92
Today|||52-Week Range
10.97
-0.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line-8.6M-7.0M-4.9M-5.7M
 
 
 
 
 
Depreciation55.0K55.0K55.0K58.0K
 
 
 
 
 
Total Other Cash Flow1.7M401.0K-1.4M-3.6M
 
 
 
 
 
Funds From Operations-6.9M-6.6M-6.2M-9.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-5.1M-3.6M-484.0K-2.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-1.8M-2.9M-5.8M-6.9M
 
 
 
 
 
 
InvestingIncrease In Investments-51.0K-164.0K-5.1M-14.2M
 
 
 
 
 
Decrease In Investments15.8M9.1M1.0K48.0K
 
 
 
 
 
Capital Expenditures-7.0K-60.0K-13.0K-2.0K
 
 
 
 
 
Net Cash Flow Investing15.7M8.9M-5.1M-14.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale30.0K2.9M19.5M2.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.003.2M-314.0K-2.9M
 
 
 
 
Other Uses - Financing0.000.0028.0K1.0K
 
 
 
Net Cash Flow - Financing30.0K6.0M19.2M13.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.0K-1.0K2.0K-1.0K
 
 
 
 
 
 
Net Change In Cash14.0M12.0M8.3M-21.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account